The U.S. colorectal cancer screening industry offers various screening tests such as Fecal occult blood tests (FOBT), Flexible sigmoidoscopy, Colonoscopy, CT colonography, and biomarker tests which help in early detection of colorectal cancer, the second leading cause of cancer-related deaths in the United States. Colorectal cancer screening helps detect polyps or cancer at an early stage when treatment is most effective. The various screening tests aid in identifying early signs of colorectal cancer, determining the need for medical follow up, and guiding treatment decisions.

The Global Colorectal Cancer Screening Market Size is estimated to be valued at US$ 5,952.2 Mn in 2024 and is expected to exhibit a CAGR of 7.5% over the forecast period 2024-2031.

Key Takeaways

Key players operating in the U.S. Colorectal Cancer Screening are Polymedco Inc., Eiken Chemical Co. Ltd., Sysmex Corporation, Quidel Corporation, Novigenix SA and Among Others. The increasing prevalence of colorectal cancer and initiatives by governing bodies to spread awareness about screening programs have accelerated the demand for various colorectal cancer screening tests in the country. Major companies are investing heavily in research and development to introduce advanced and non-invasive screening solutions to gain a competitive edge in the market.

The growing demand for minimally invasive screening procedures and rise in healthcare expenditure are fueling the global expansion of the U.S colorectal cancer screening industry. With increasing healthcare awareness, various diagnostic chains and hospitals are installing advanced colorectal cancer screening solutions to cater to the growing patient volume which is contributing to the industry’s growth.

Market Drivers

The key driver for the growth of the U.S. colorectal cancer screening market is increasing awareness about early detection through screening initiatives by associations like the American Cancer Society. Regular screening helps detect the disease at early stages when treatment is most effective. As per estimates, around 60% of deaths from colorectal cancer could be avoided with regular screening. Thus, campaigns to encourage screening participation and educate people about screening guidelines are positively impacting the uptake of various screening tests in the country.

Impact of geopolitical situation on the U.S. Colorectal Cancer Screening market growth:

The growth of the U.S. Colorectal Cancer Screening market is influenced by the ongoing geopolitical tensions and conflicts across various regions. Issues like sanctions, trade wars and limits on technology transfers are disrupting global supply chains and movement of healthcare equipment and diagnostic products. This is posing challenges for manufacturers in smoothly supplying screening products and necessary medical goods to the US. Market players need to closely monitor changing policies and consider alternative sourcing options to minimize supply disruptions. They also require building flexibility in operations to respond quickly to any trade or export restrictions imposed on key raw material exporting countries. Additionally, political instability or conflicts in large product manufacturing hubs can negatively impact timely product availability. The market demands strategies to mitigate risks from such external uncertainties through steps like inventory management and diversifying production bases.

Regional focus- Western United States:

The Western region of the US, including states like California, Washington and Colorado, account for the largest share of the country's Colorectal Cancer Screening market in terms of value. This is due to factors like high disposable incomes, better access to quality healthcare facilities, higher cancer awareness levels and proactive government programs promoting regular screening. The region is an early adapter of new screening technologies and diagnostic tools. It also acts as a strategic base for many international players looking to enter the US market. Various research collaborations between leading academic institutions and diagnostic companies in the West further augment the regional market growth.

Fastest growing region- Southern United States:

The Southern states spanning Texas, Florida and others represent the fastest expanding segment of the US Colorectal Cancer Screening industry. This growth can be attributed to rising healthcare expenditures in these regions combined with initiatives to broaden insurance coverage. Since Screening rates remain relatively lower here compared to other areas, there lies plenty of penetration potential. Also, the population demographic consisting of larger elderly base prone to colorectal cancer diagnoses favors future demand. Market players are actively launching awareness drives and tie-ups with local healthcare facilities to leverage opportunities from this high growth, untapped market.

What Are The Key Data Covered In This U.S. Colorectal Cancer Screening Market Report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the U.S. Colorectal Cancer Screening Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the U.S. Colorectal Cancer Screening Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behaviour

:- U.S. Colorectal Cancer Screening Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of U.S. Colorectal Cancer Screening Market vendors

FAQ’S

Q.1 What are the main factors influencing the U.S. Colorectal Cancer Screening market?

Q.2 Which companies are the major sources in this industry?

Q.3 What are the market’s opportunities, risks, and general structure?

Q.4 Which of the top U.S. Colorectal Cancer Screening Market companies compare in terms of sales, revenue, and prices?

Q.5 Which businesses serve as the U.S. Colorectal Cancer Screening market’s distributors, traders, and dealers?

Q.6 How are market types and applications and deals, revenue, and value explored?

Q.7 What does a business area’s assessment of agreements, income, and value implicate?

 
Get more insights on this topic: https://uconnect.ae/read-blog/54446